Revvity (NYSE:RVTY) Sets New 52-Week Low – Should You Sell?

Shares of Revvity, Inc. (NYSE:RVTY) hit a new 52-week low on Friday . The stock traded as low as $93.54 and last traded at $95.09, with a volume of 630768 shares traded. The stock had previously closed at $100.75.

Analyst Ratings Changes

Several analysts recently weighed in on RVTY shares. Barclays lifted their price objective on Revvity from $135.00 to $140.00 and gave the company an “overweight” rating in a report on Monday, February 3rd. Raymond James reissued an “outperform” rating and set a $145.00 target price (up previously from $140.00) on shares of Revvity in a research report on Monday, February 3rd. Sanford C. Bernstein cut shares of Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 price target for the company. in a research report on Friday, January 10th. KeyCorp lifted their price objective on shares of Revvity from $132.00 to $145.00 and gave the company an “overweight” rating in a report on Monday, February 3rd. Finally, Bank of America upgraded Revvity from a “neutral” rating to a “buy” rating and set a $138.00 target price for the company in a report on Friday, December 13th. Four investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $136.25.

Revvity Price Performance

The stock has a 50-day moving average price of $113.18 and a two-hundred day moving average price of $116.49. The stock has a market cap of $11.39 billion, a price-to-earnings ratio of 42.89, a PEG ratio of 3.82 and a beta of 1.07. The company has a current ratio of 3.60, a quick ratio of 3.03 and a debt-to-equity ratio of 0.41.

Revvity (NYSE:RVTY) last issued its quarterly earnings results on Friday, January 31st. The company reported $1.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same quarter last year, the business posted $1.25 EPS. As a group, equities research analysts forecast that Revvity, Inc. will post 4.94 EPS for the current year.

Revvity Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Friday, April 18th will be paid a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a yield of 0.30%. The ex-dividend date of this dividend is Thursday, April 17th. Revvity’s payout ratio is 12.67%.

Insider Buying and Selling

In related news, insider Joel S. Goldberg sold 15,170 shares of the stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $126.73, for a total transaction of $1,922,494.10. Following the sale, the insider now directly owns 33,400 shares of the company’s stock, valued at approximately $4,232,782. This represents a 31.23 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Tajinder S. Vohra sold 5,492 shares of the firm’s stock in a transaction dated Tuesday, January 7th. The shares were sold at an average price of $116.81, for a total value of $641,520.52. Following the sale, the insider now owns 19,652 shares in the company, valued at $2,295,550.12. This trade represents a 21.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.68% of the stock is currently owned by corporate insiders.

Institutional Trading of Revvity

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Versant Capital Management Inc grew its position in shares of Revvity by 489.0% in the first quarter. Versant Capital Management Inc now owns 1,814 shares of the company’s stock valued at $192,000 after purchasing an additional 1,506 shares during the period. Wellington Management Group LLP boosted its position in Revvity by 13.2% during the fourth quarter. Wellington Management Group LLP now owns 6,655 shares of the company’s stock worth $743,000 after acquiring an additional 776 shares during the last quarter. Wealth Enhancement Advisory Services LLC raised its holdings in Revvity by 20.4% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 4,952 shares of the company’s stock valued at $553,000 after acquiring an additional 838 shares during the last quarter. Dogwood Wealth Management LLC lifted its stake in Revvity by 16.8% in the 4th quarter. Dogwood Wealth Management LLC now owns 4,987 shares of the company’s stock worth $557,000 after purchasing an additional 717 shares in the last quarter. Finally, Siemens Fonds Invest GmbH boosted its holdings in shares of Revvity by 264.8% during the 4th quarter. Siemens Fonds Invest GmbH now owns 13,357 shares of the company’s stock worth $1,491,000 after purchasing an additional 9,696 shares during the last quarter. 86.65% of the stock is currently owned by hedge funds and other institutional investors.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.